SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-24-004326
Filing Date
2024-03-29
Accepted
2024-03-29 08:06:07
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kala-20231231x10k.htm   iXBRL 10-K 3272868
2 EX-3.1 kala-20231231xex3d1.htm EX-3.1 339478
3 EX-4.3 kala-20231231xex4d3.htm EX-4.3 27921
4 EX-21.1 kala-20231231xex21d1.htm EX-21.1 5252
5 EX-23.1 kala-20231231xex23d1.htm EX-23.1 2572
6 EX-31.1 kala-20231231xex31d1.htm EX-31.1 8955
7 EX-31.2 kala-20231231xex31d2.htm EX-31.2 8926
8 EX-32.1 kala-20231231xex32d1.htm EX-32.1 5194
9 EX-4.2 kala-20231231xex4d2.htm EX-4.2 6112
10 EX-97.1 kala-20231231xex97d1.htm EX-97.1 19865
11 GRAPHIC kala-20231231x10k006.jpg GRAPHIC 42707
12 GRAPHIC kala-20231231x10k007.jpg GRAPHIC 65834
13 GRAPHIC kala-20231231x10k008.jpg GRAPHIC 35606
14 GRAPHIC kala-20231231x10k009.jpg GRAPHIC 20097
15 GRAPHIC kala-20231231x10k010.jpg GRAPHIC 45242
16 GRAPHIC kala-20231231x10k011.jpg GRAPHIC 28954
17 GRAPHIC kala-20231231x10k012.jpg GRAPHIC 44551
  Complete submission text file 0001558370-24-004326.txt   14511663

Data Files

Seq Description Document Type Size
18 EX-101.SCH kala-20231231.xsd EX-101.SCH 97983
19 EX-101.CAL kala-20231231_cal.xml EX-101.CAL 82199
20 EX-101.DEF kala-20231231_def.xml EX-101.DEF 493190
21 EX-101.LAB kala-20231231_lab.xml EX-101.LAB 844263
22 EX-101.PRE kala-20231231_pre.xml EX-101.PRE 717390
126 EXTRACTED XBRL INSTANCE DOCUMENT kala-20231231x10k_htm.xml XML 2076801
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38150 | Film No.: 24802072
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)